Ali E, Al-Sadi A, Ali S, Rozi W, Idriss M, Jain M
Cureus. 2025; 16(12):e76702.
PMID: 39898138
PMC: 11782904.
DOI: 10.7759/cureus.76702.
Zhao X, Zhang L, Zhang X, Hao M, Chen S, Wei J
Zhonghua Xue Ye Xue Za Zhi. 2025; 45(12):1125-1128.
PMID: 39765354
PMC: 11886705.
DOI: 10.3760/cma.cn121090-20240612-00221.
Shi J, Ozcan Y, Santos C, Patel H, Shammo J, Bat T
Ther Adv Hematol. 2024; 15:20406207241307500.
PMID: 39734592
PMC: 11672493.
DOI: 10.1177/20406207241307500.
Du Y, Wang D, Hu Q, Lai Z, Yang C, He H
J Cell Mol Med. 2024; 28(23):e70295.
PMID: 39671267
PMC: 11640899.
DOI: 10.1111/jcmm.70295.
Wong R, Jang J, Wong L, Kim J, Rojnuckarin P, Goh Y
Int J Mol Sci. 2024; 25(22).
PMID: 39596227
PMC: 11594386.
DOI: 10.3390/ijms252212160.
Thrombosis in Paroxysmal Nocturnal Hemoglobinuria (PNH): From Pathogenesis to Treatment.
Kokoris S, Polyviou A, Evangelidis P, Grouzi E, Valsami S, Tragiannidis K
Int J Mol Sci. 2024; 25(22).
PMID: 39596172
PMC: 11594924.
DOI: 10.3390/ijms252212104.
Health-related quality of life and symptom-specific functional impairment among patients treated with parenterally administered complement inhibitors for paroxysmal nocturnal hemoglobinuria.
Dingli D, Rizio A, Broderick L, LaGasse K, Rucker S, Carty M
Ann Hematol. 2024; 103(12):5213-5227.
PMID: 39551895
PMC: 11695468.
DOI: 10.1007/s00277-024-06088-x.
Targeted management of coexistent severe thrombophilias-A case report of a successful pregnancy despite paroxysmal nocturnal hemoglobinuria and hereditary protein C deficiency.
Dereme J, Goodyer M, Baud D, Alberio L, Grandoni F, Gavillet M
EJHaem. 2024; 5(5):1048-1052.
PMID: 39415927
PMC: 11474299.
DOI: 10.1002/jha2.972.
A machine learning algorithm for the detection of paroxysmal nocturnal haemoglobinuria (PNH) in UK primary care electronic health records.
Worker A, Mahon H, Sams J, Boardman-Pretty F, Marchini E, Dubis R
Orphanet J Rare Dis. 2024; 19(1):378.
PMID: 39396996
PMC: 11479535.
DOI: 10.1186/s13023-024-03406-4.
Paroxysmal Nocturnal Hemoglobinuria, Pathophysiology, Diagnostics, and Treatment.
Panse J, Hochsmann B, Schubert J
Transfus Med Hemother. 2024; 51(5):310-320.
PMID: 39371251
PMC: 11452172.
DOI: 10.1159/000540474.
Navigating the Complement Pathway to Optimize PNH Treatment with Pegcetacoplan and Other Currently Approved Complement Inhibitors.
Hillmen P, Horneff R, Yeh M, Kolev M, Deschatelets P
Int J Mol Sci. 2024; 25(17).
PMID: 39273426
PMC: 11395449.
DOI: 10.3390/ijms25179477.
Clinical characteristics and management of paroxysmal nocturnal haemoglobinuria in Latin America: a narrative review.
Goldschmidt V, Apodaca E, Galvez K, Wannesson B, Scheinberg P
Ann Hematol. 2024; .
PMID: 39235489
DOI: 10.1007/s00277-024-05968-6.
[Analysis and summary of clinical characteristics of 289 patients with paroxysmal nocturnal hemoglobinuria in Zhejiang Province].
Xu G, Jin W, Ye B, Jiang S, Hu C, Huang X
Zhonghua Xue Ye Xue Za Zhi. 2024; 45(6):549-555.
PMID: 39134485
PMC: 11310803.
DOI: 10.3760/cma.j.cn121090-20240127-00041.
An Interesting Case of Paroxysmal Nocturnal Hemoglobinuria With Renal Involvement.
Keating S, Machchhar R, Jain U, Naronowicz G, Lipschutz J
Cureus. 2024; 16(7):e63917.
PMID: 39104998
PMC: 11298764.
DOI: 10.7759/cureus.63917.
Iptacopan and danicopan for paroxysmal nocturnal hemoglobinuria.
Fahim S, Makam A, Suh K, Carlson J, Richardson M, Herce-Hagiwara B
J Manag Care Spec Pharm. 2024; 30(6):618-623.
PMID: 38824627
PMC: 11145001.
DOI: 10.18553/jmcp.2024.30.6.618.
Eculizumab for paroxysmal nocturnal hemoglobinuria: Two cases of successful pregnancy outcomes.
Ilic J, Pujic B, Jakovljevic B, Sekulic B, Agic D, El Farra A
Clin Case Rep. 2024; 12(5):e8900.
PMID: 38725930
PMC: 11079538.
DOI: 10.1002/ccr3.8900.
Health-related quality of life and influencing factors of patients with paroxysmal nocturnal hemoglobinuria in China.
Yu H, Duan S, Wang P, Fu R, Lv Z, Yu Y
Orphanet J Rare Dis. 2024; 19(1):186.
PMID: 38702811
PMC: 11067208.
DOI: 10.1186/s13023-024-03178-x.
Comparison of human leukocyte antigen in patients with paroxysmal nocturnal hemoglobinuria of different clone sizes.
Zhang Z, Hu Q, Yang C, Chen M, Han B
Ann Hematol. 2024; 103(6):1897-1907.
PMID: 38616191
DOI: 10.1007/s00277-024-05740-w.
[Eculizumab in patients with paroxysmal nocturnal hemoglobinuria: a real-world study in China].
Wang L, Hu Q, Chen M, Yang C, Han B
Zhonghua Xue Ye Xue Za Zhi. 2024; 45(2):184-189.
PMID: 38604796
PMC: 11078682.
DOI: 10.3760/cma.j.cn121090-20231106-00250.
Fatigue Item Response among Hemoglobin-Normalized Patients with Paroxysmal Nocturnal Hemoglobinuria: PEGASUS Trial Results at 16 and 48 Weeks.
Schwartz C, Borowiec K, Min J, Fishman J
J Clin Med. 2024; 13(6).
PMID: 38541928
PMC: 10970719.
DOI: 10.3390/jcm13061703.